|1.||Rabinovitch, Nathan: 8 articles (02/2014 - 05/2006)|
|2.||Taniguchi, M: 8 articles (01/2009 - 11/2001)|
|3.||Mita, H: 8 articles (01/2009 - 11/2001)|
|4.||Akiyama, K: 8 articles (01/2009 - 11/2001)|
|5.||Higashi, N: 6 articles (01/2009 - 06/2003)|
|6.||Kanaoka, Yoshihide: 5 articles (12/2013 - 08/2007)|
|7.||Dal Negro, R W: 4 articles (12/2012 - 01/2006)|
|8.||Micheletto, C: 4 articles (12/2012 - 01/2006)|
|9.||Taniguchi, Masami: 4 articles (09/2012 - 02/2004)|
|10.||Higashi, Noritaka: 4 articles (09/2012 - 02/2004)|
|1.||Asthma (Bronchial Asthma)
12/01/1997 - "In atopic asthmatics, urinary excretion of LTE4 and 11DTXB2 was significantly higher on admission with an asthma attack, and returned to control levels when the patients were in the improved state (179+/-29 to 65+/-16 ng/day in LTE4, 1,085+/-250 to 440+/-90 ng/day in 11DTXB2). "
11/01/1995 - "Although the magnitude of variation in LTE4 excretion within a day was significantly greater in patients with asthma than in normal subjects (p < 0.05), we could not identify any specific diurnal variation pattern in either the normal or the asthma group. "
11/01/1999 - "Just after the onset of an asthma attack, urinary LTE4 levels reflected the severity of the attack and decreased during the course of clinical improvement with various therapies; however, they did not change in the course of an attack in one of five patients. "
01/01/2014 - "The goal of this study was to evaluate the impact of urinary leukotriene E4 (ULTE4) in asthmatic children during acute asthma exacerbation. "
01/01/2014 - "Study of urinary leukotriene E4 levels in children with acute asthma."
03/01/2012 - "Furthermore, urinary LTE4 concentrations are of potential use as a marker of inflammation in dogs with CCE."
07/01/1991 - "In certain situations, urinary LTE4 levels may be useful as a marker of the degree of inflammation."
10/01/2000 - "Urinary LTE4 and EPX are useful markers of airway inflammation and can be helpful in guiding asthma management. "
03/01/2012 - "Urinary leukotriene E4 concentrations as a potential marker of inflammation in dogs with inflammatory bowel disease."
11/01/2001 - "Our findings suggested that basal LTE4 in urine reflected chronic airway inflammation of asthma."
|3.||Airway Obstruction (Choking)
09/01/2006 - "Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction."
05/01/1995 - "In addition, a post-challenge increase in urinary LTE4 levels was detected in association with allergen-induced airway obstruction in atopic asthmatics. "
07/01/1992 - "Recovery of leukotriene E4 from the urine of patients with airway obstruction."
11/01/1998 - "Finally, increased LTE4 supports the contribution of the leukotrienes to airway obstruction during both phases of the asthmatic response to allergen."
09/01/1989 - "Thus, although LTD4 and LTE4 are though to act on the same or similar receptors, the pattern of pharmacologic reversal at comparable levels of airway obstruction differs for these two agonists."
|4.||Chronic Obstructive Pulmonary Disease (COPD)
01/01/2012 - "We also did not find any difference between LTE4 level in urine and 9α11βPGF(2) in blood and urine between exacerbated and stable COPD. "
03/01/1997 - "Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease."
04/01/2007 - "Leukotriene E(4) (LTE(4)) is implicated in asthma pathophysiology and possibly in chronic obstructive pulmonary disease (COPD) as one of the causes of persistent bronchoconstriction and mucus hypersecretion. "
04/01/2007 - "Leukotriene E(4) in urine in patients with asthma and COPD--the effect of smoking habit."
03/01/1997 - "The mean leukotriene E4 level in patients with COPD during remission, during acute exacerbation before and after prednisolone treatment were 16.8[4.02], 41.7[21.9], and 19.5[3.78] pg/ml (mean[SD]), respectively. "
|5.||Pulmonary Hypertension (Ayerza Syndrome)
01/01/1997 - "These data suggest that neither the surgical repair during cardiopulmonary bypass nor the pulmonary hypertension appeared to modify the leukotriene E4 blood levels in the small number of patients studied."
01/01/2000 - "Since urinary LTE4 excretion is increased in various cardiovascular diseases, including arterial pulmonary hypertension or cardiac ischaemia, the study of the effects of leukotrienes on human vascular preparations is of interest. "
09/01/1992 - "We conclude that 1) the extended pulmonary hypertension induced by PAF was caused mainly by prolonged activation of 5-lipoxygenase with LTC4 production, 2) the relative overall lung clearance of LTB4, LTD4, and LTE4 was slower than that of LTC4, and 3) LTB4, LTD4, and LTE4 had no appreciable pressor effect."
|10.||Histamine (Histamine Dihydrochloride)
|2.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)